Quarterly Result2 Nov 2026, 02:54 pm
P&G Health Q2 Results: Sales Up 18%, PAT Up 26%
AI Summary
Procter & Gamble Health Ltd. announced its second-quarter financial results for the period ended September 30, 2026. The company reported sales of ₹376 crores, an increase of 18% compared to the previous year. Profit After Tax (PAT) stood at ₹112 crores, marking a 26% year-on-year growth. This performance was attributed to strong brand fundamentals, effective retail execution, successful new product innovations, and enhanced go-to-market strategies. The company highlighted its focus on science-backed healthcare products and a strategy centered on a focused portfolio of trusted brands, superiority, productivity, and an agile organization.
Key Highlights
- Sales grew by 18% to ₹376 crores in Q2 FY27.
- PAT increased by 26% to ₹112 crores year-on-year.
- Growth driven by brand strength and retail execution.
- Company emphasizes science-backed products and innovation.
- Strategy focuses on brand superiority and productivity.
Price Impact
More from PGHL